1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Canada >
  5. Quebec >
  6. Antibe Therapeutics Acquires Citagenix

M&A Deal Summary

Antibe Therapeutics Acquires Citagenix

On October 6, 2015, Antibe Therapeutics acquired life science company Citagenix

Acquisition Highlights
  • This is Antibe Therapeutics’ 1st transaction in the Life Science sector.
  • This is Antibe Therapeutics’ 1st transaction in Canada.
  • This is Antibe Therapeutics’ 1st transaction in Quebec.

M&A Deal Summary
Date 2015-10-06
Target Citagenix
Sector Life Science
Buyer(s) Antibe Therapeutics
Deal Type Add-on Acquisition

Target

Citagenix

Montreal, Quebec, Canada
Citagenix Inc. is a Canadian sales and distribution company with a focus on regenerative medicine.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Antibe Therapeutics

Toronto, Ontario, Canada
Category Company
Sector Medical Products
DESCRIPTION

Antibe Therapeutics is a human drug development company with a portfolio of patented anti-inflammatory drug candidates targeting significant global markets.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Quebec M&A 1 of 1
Country: Canada M&A 1 of 1
Year: 2015 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal